Original Article
Association of Nut Consumption with Total and Cause-Specific Mortality
N Engl J Med 2013; 369:2001-2011November 21, 2013DOI: 10.1056/NEJMoa1307352
- Abstract
Background
Increased nut consumption has been associated with a reduced risk of major chronic diseases, including cardiovascular disease and type 2 diabetes mellitus. However, the association between nut consumption and mortality remains unclear.
Methods
We examined the association between nut consumption and subsequent total and cause-specific mortality among 76,464 women in the Nurses' Health Study (1980–2010) and 42,498 men in the Health Professionals Follow-up Study (1986–2010). Participants with a history of cancer, heart disease, or stroke were excluded. Nut consumption was assessed at baseline and updated every 2 to 4 years.
Results
During 3,038,853 person-years of follow-up, 16,200 women and 11,229 men died. Nut consumption was inversely associated with total mortality among both women and men, after adjustment for other known or suspected risk factors. The pooled multivariate hazard ratios for death among participants who ate nuts, as compared with those who did not, were 0.93 (95% confidence interval [CI], 0.90 to 0.96) for the consumption of nuts less than once per week, 0.89 (95% CI, 0.86 to 0.93) for once per week, 0.87 (95% CI, 0.83 to 0.90) for two to four times per week, 0.85 (95% CI, 0.79 to 0.91) for five or six times per week, and 0.80 (95% CI, 0.73 to 0.86) for seven or more times per week (P<0.001 for trend). Significant inverse associations were also observed between nut consumption and deaths due to cancer, heart disease, and respiratory disease.
Conclusions
In two large, independent cohorts of nurses and other health professionals, the frequency of nut consumption was inversely associated with total and cause-specific mortality, independently of other predictors of death. (Funded by the National Institutes of Health and the International Tree Nut Council Nutrition Research and Education Foundation.)
Media in This Article
Video
Nut Consumption and Mortality
Figure 1
Hazard Ratios for Death from Any Cause and from Specific Causes, According to Frequency of Nut Consumption and Type of Nut.Figure 2
Hazard Ratios for Death from Any Cause in Subgroups.Article Activity
- Article
Video
Nut Consumption and Mortality
Nuts are nutrient-dense foods that are rich in unsaturated fatty acids, fiber, vitamins, minerals, and many other bioactive substances, such as phenolic antioxidants and phytosterols.1,2 Observational studies and clinical trials have suggested that nut consumption has beneficial effects on coronary heart disease1 and its intermediate biomarkers (e.g., blood cholesterol).3 On the basis of these findings, the Food and Drug Administration concluded in 2003 that for most nuts, consumption of 43 g (1.5 oz) per day, as part of a low-fat diet, “may reduce the risk of heart disease.”4 More recently, a randomized primary-prevention trial involving persons at high cardiovascular risk showed a significant reduction in major cardiovascular events among participants assigned to a Mediterranean diet — one component of which was supplementation with walnuts, hazelnuts, or almonds — as compared with a control diet.5
Observational and intervention studies of nut consumption have also shown reductions in various mediators of chronic diseases, including oxidative stress,6,7 inflammation,8 visceral adiposity,9 hyperglycemia,6,9,10 insulin resistance,11,12 and endothelial dysfunction.13 In prospective cohort studies, increased nut intake has been associated with reduced risks of type 2 diabetes mellitus,14-16 the metabolic syndrome,17 colon cancer,18 hypertension,19 gallstone disease,20,21 diverticulitis,22 and death from inflammatory diseases.23
Despite these inverse associations between nut intake and several major chronic diseases, few studies have investigated nut consumption in relation to total mortality, and these investigations have often been limited by small samples, single assessment of diet and other covariates, or inadequate adjustment for important confounding factors.24-31 We therefore examined the association of nut consumption with total and cause-specific mortality in two large, independent cohort studies of nurses and other health professionals. These studies provide repeated measures of diet (including separate data on peanuts and tree nuts), extensive data on known or suspected confounding variables, 30 years of follow-up, and data on more than 27,000 deaths for analysis.
Methods
Study Population
The Nurses' Health Study (NHS) is a prospective cohort study of 121,700 female nurses from 11 U.S. states; participants were enrolled in 1976. The Health Professionals Follow-up Study (HPFS) is a prospective cohort study of 51,529 male health professionals from all 50 states, enrolled in 1986. Follow-up questionnaires are sent biennially to update medical and lifestyle information. Follow-up rates exceed 90% in each 2-year cycle for both cohorts.
For this analysis, we defined baseline as the year of the first validated food-frequency questionnaire in each study — 1980 for the NHS and 1986 for the HPFS. At baseline, 92,468 women in the NHS and 49,934 men in the HPFS completed the dietary questionnaire. We excluded 5611 women and 5939 men with a history of cancer, heart disease, or stroke; 1113 women and 340 men who did not provide information on nut intake; and 9280 women and 1157 men who did not provide information on anthropometric measures or physical activity. The final analyses included 76,464 women in the NHS and 42,498 men in the HPFS.
The authors assume full responsibility for the analyses and interpretation of the data in this study. The funders of the study had no role in its design or conduct; in the collection, management, analysis, or interpretation of the data; or in the preparation, review, or approval of the manuscript. The study was approved by the human subjects committees at Brigham and Women's Hospital and Harvard School of Public Health, and all participants provided written informed consent. In addition, the study was approved by the Connecticut Department of Public Health Human Investigations Committee, and some data used in the study were obtained from the Connecticut Department of Public Health.
Dietary Assessment
Dietary intake was measured with the use of validated food-frequency questionnaires administered every 2 to 4 years. In the 1980 and 1984 dietary questionnaires, we asked the participants how often they had consumed a serving of nuts (serving size, 28 g [1 oz]) during the preceding year: never or almost never, one to three times a month, once a week, two to four times a week, five or six times a week, once a day, two or three times a day, four to six times a day, or more than six times a day. In the subsequent dietary questionnaires, the question regarding nuts was split into two items: peanuts and other nuts. Total nut consumption was defined as the intake of peanuts and other nuts. A validation study of the food-frequency questionnaire indicated that nut intake was reported reasonably accurately; the correlation coefficient was 0.75 for the correlation between intake assessed on the baseline dietary questionnaire and intake assessed on four 1-week dietary records.32
Ascertainment of Deaths
Our primary end point was death from any cause. We performed systematic searches of the vital records of states and of the National Death Index. This search was supplemented by reports from family members and postal authorities. With the use of these methods, we were able to ascertain more than 98% of the deaths in each cohort.33
A physician who was unaware of the data on nut consumption and other risk factors reviewed death certificates and medical records to classify the cause of death according to the eighth and ninth revisions of the International Classification of Diseases. Deaths were grouped into nine major categories (Table S1 in the Supplementary Appendix, available with the full text of this article at NEJM.org).
Statistical Analysis
To better represent long-term diet and to minimize any effects of within-person variation, we calculated the cumulative average of nut consumption. Because participants may alter dietary patterns after the diagnosis of a major illness, we suspended further updating of all dietary variables when participants reported a diagnosis of stroke, heart disease, angina, or cancer, although follow-up continued until death or the end of the study period.
We used Cox proportional-hazards models to estimate hazard ratios and 95% confidence intervals. Multivariate models were adjusted for known or suspected predictors of death. P values for trend were calculated with the use of the Wald test of a score variable based on the median number of servings of nuts consumed per day for each category of nut consumption. We also used restricted-cubic-spline regression to flexibly model the association.
We conducted several sensitivity analyses to test the robustness of the results. To minimize the influence of smoking or an extremely low or high body-mass index (BMI; the weight in kilograms divided by the square of the height in meters) on the results, we excluded participants who had ever smoked or who had a BMI of less than 18.5 or more than 40. We also excluded participants who had diabetes at baseline, and we suspended updating of dietary variables after a diagnosis of diabetes during study follow-up. To assess the influence of total sodium intake, adherence to a Mediterranean diet (as assessed by the Mediterranean-diet score34), and olive-oil intake on the results, we conducted separate analyses with adjustment for each of these variables. Finally, we conducted an analysis in which updating of dietary variables was continued even after a participant reported a diagnosis of a major chronic disease.
To address the concern that occult chronic diseases in the years that preceded diagnosis may have influenced dietary patterns, in the analysis in which we continuously updated dietary information after diagnosis of chronic disease, we excluded the first 2 years of follow-up data and added a 2-year lag period between nut-intake assessment and each follow-up period (e.g., in the NHS, we used nut intake from the 1980 questionnaire for the follow-up period from 1982 to 1984, and so forth).
To address the possibility of residual confounding by measured variables, we further adjusted for a propensity score that reflected associations of nut consumption with the other variables in the multivariate-adjusted model.35 In addition, to estimate the influence of unmeasured confounding on the results, we used the array-approach sensitivity analysis described by Schneeweiss36 in order to determine how strong and imbalanced the confounder would need to be to reduce an association to nonsignificance. We performed separate secondary analyses for peanuts and tree nuts, as well as analyses stratified by other risk factors. For these analyses, we combined categories of high nut intake to maintain statistical power. The likelihood-ratio test was used to test for interaction.
The hazard ratios from multivariate models in each cohort were pooled with the use of the random-effects model, which allowed for between-study heterogeneity. P values for heterogeneity were calculated with the use of the Q statistic. Analyses were performed with the SAS statistical package (version 9.1, SAS Institute). Statistical tests were two-sided, and P values of less than 0.05 were considered to indicate statistical significance.
Results
Nut Consumption and Dietary and Lifestyle Factors
During the study follow-up period, nut consumption remained relatively constant (Table S2 in the Supplementary Appendix). As compared with participants who consumed nuts less frequently, those who consumed nuts more frequently were leaner, less likely to smoke, more likely to exercise, and more likely to use multivitamin supplements; they also consumed more fruits and vegetables and drank more alcohol (Table 1Table 1
Characteristics of Person-Years According to Frequency of Nut Consumption., and Table S3 in the Supplementary Appendix).Nut Consumption and Total Mortality
During 30 years of follow-up (2,135,482 person-years) among women in the NHS, we documented 16,200 deaths; during 24 years of follow-up (903,371 person-years) among men in the HPFS, we documented 11,229 deaths. Age-adjusted and multivariate-adjusted analyses showed a significant inverse association between frequency of nut consumption and total mortality among both women and men (Table 2Table 2
Total Mortality, According to Frequency of Nut Consumption.). P values for heterogeneity between women and men were greater than 0.05 for all categories of nut consumption; therefore, we pooled results from these independent cohort studies. The pooled multivariate hazard ratios for death for participants who ate nuts, as compared with those who did not eat nuts, were 0.93 (95% confidence interval [CI], 0.90 to 0.96) for nut consumption less than once per week, 0.89 (95% CI, 0.86 to 0.93) for once per week, 0.87 (95% CI, 0.83 to 0.90) for two to four times per week, 0.85 (95% CI, 0.79 to 0.91) for five or six times per week, and 0.80 (95% CI, 0.73 to 0.86) for seven or more times per week (P<0.001 for trend). The restricted cubic splines showed a pattern similar to the categorical analysis, and similar patterns were observed among women and men (Fig. S1 in the Supplementary Appendix).Nut Consumption and Cause-Specific Mortality
In multivariate analyses, nut consumption was inversely associated with the risk of most major causes of death among both women and men (Figure 1Figure 1
Hazard Ratios for Death from Any Cause and from Specific Causes, According to Frequency of Nut Consumption and Type of Nut., and Table S4 in the Supplementary Appendix). In the pooled analysis of women and men, significant inverse associations were observed for deaths due to cancer, heart disease, and respiratory disease (Table 3Table 3
Cause-Specific Mortality, According to Frequency of Nut Consumption.).Sensitivity Analyses
The significant inverse association between nut consumption and total mortality remained largely unchanged when we excluded participants who had ever smoked or who had an extremely high or low BMI; when we excluded participants with diabetes at baseline and suspended updating of dietary variables after a diagnosis of diabetes; when we adjusted for total sodium intake, Mediterranean-diet score, olive-oil intake, and a propensity score that predicted nut intake levels; when we continued to update dietary information after diagnosis of a chronic disease; and when we excluded the first 2 years of follow-up and added a 2-year lag period between nut-intake assessment and each follow-up period (Table S5 in the Supplementary Appendix). Furthermore, the array-approach sensitivity analysis36 showed that an unmeasured confounder would have to be strongly associated with mortality (e.g., predicted relative risk, ≤0.60) or substantially imbalanced between participants who ate nuts and those who did not (e.g., ≥40% difference in prevalence between those who eat nuts seven or more times per week vs. never) in order to attenuate the inverse association sufficiently so that it that was no longer significant (Tables S6 and S7 in the Supplementary Appendix).
Subgroup Analyses
In separate analyses of the consumption of peanuts and tree nuts, the associations with total and cause-specific mortality were similar for the two types of nuts (Figure 1, and Table S8 in the Supplementary Appendix). When consumption of nuts two or more times per week was compared with no nut consumption, the pooled multivariate-adjusted hazard ratios for death were 0.88 (95% CI, 0.84 to 0.93) for peanuts and 0.83 (95% CI, 0.79 to 0.88) for tree nuts.
In analyses stratified by other potential risk factors for death, the inverse association between nut consumption and total mortality persisted in all subgroups (Figure 2Figure 2
Hazard Ratios for Death from Any Cause in Subgroups., and Table S9 in the Supplementary Appendix). Although a significant inverse association was observed across all strata of BMI, the association was stronger among overweight or obese participants than among normal-weight participants (P=0.04 for interaction).Discussion
In two large prospective U.S. cohorts, we found a significant, dose-dependent inverse association between nut consumption and total mortality, after adjusting for potential confounders. As compared with participants who did not eat nuts, those who consumed nuts seven or more times per week had a 20% lower death rate. Inverse associations were observed for most major causes of death, including heart disease, cancer, and respiratory diseases. Results were similar for peanuts and tree nuts, and the inverse association persisted across all subgroups.
Our results are consistent with the findings in previous, smaller studies. The Adventist Health Study showed that, as compared with nut consumption less than once per week, consumption five or more times per week was associated with reduced total mortality among whites,24 blacks,25 and elderly persons,26 with hazard ratios ranging from 0.56 to 0.82. Similarly, a study of a U.K. cohort,27 the Iowa Women's Health Study,28 the Netherlands Cohort Study,30 and an earlier analysis of the NHS29 all showed significant inverse associations between nut intake and total mortality. Finally, in a recent secondary analysis within the PREDIMED (Prevención con Dieta Mediterránea) trial,31 a hazard ratio for death of 0.61 (95% CI, 0.45 to 0.83) was found for consumption of more than three servings of nuts per week, as compared with no nut consumption.
Several explanations for our findings are possible. The observed associations could reflect confounding by unmeasured or poorly measured variables. However, participants in both cohorts provided detailed and repeated measures of diet and lifestyle, which allowed us to carefully control for a variety of potential confounding factors. To further minimize confounding by measured variables, we used the propensity-score method to adjust for differences between comparison groups, and the results remained largely unchanged. In addition, the inverse association persisted across subgroups defined by the potential confounding factors, further suggesting an independent association. We cannot rule out the possibility of confounding by unknown factors; however, the array-approach sensitivity analysis36 showed that a potential confounding effect would have to be quite large to meaningfully alter the observed associations in this study. In light of the large number of important confounding factors included in our analysis, all of which were updated regularly throughout study follow-up, it seems unlikely that such strong unmeasured confounding could fully explain the associations.
Reverse causality is another possible explanation for our findings, because people with chronic disease and poor health might abstain from nut consumption. However, we excluded participants with a history of cancer, heart disease, or stroke at baseline, and we suspended further updating of all dietary variables when participants reported a diagnosis of stroke, heart disease, angina, or cancer. Moreover, the results remained significant when we excluded the first 2 years of follow-up and added a 2-year lag period between nut-intake assessment and each follow-up period.
There may be a concern that frequent nut consumption can result in weight gain. However, in these two cohorts, increased nut intake was associated with less weight gain.37 Similarly, in other prospective cohort studies and clinical trials, increased nut consumption was associated with reduced waist circumference,38 less weight gain,39,40 and a decreased risk of obesity.40
The strengths of this study include its prospective design, large sample, 30 years of follow-up with an excellent follow-up rate, and repeated assessment of diet and lifestyle variables. However, our study has limitations. Because nut intake was self-reported, some measurement error is inevitable. However, we were able to reduce random measurement error by averaging nut intake cumulatively from multiple time points. Moreover, because dietary data were collected prospectively, misreporting could be random, resulting in an underestimation of the association. Because we lacked data on how nuts were prepared (e.g., salted, spiced, roasted, or raw), we were unable to examine the influence of preparation method on mortality. Restriction of the study sample to health professionals could reduce the generalizability of the results, but it also potentially minimizes residual confounding by socioeconomic status. In addition, metabolic processes are unlikely to differ between health professionals and the general population.
Given the observational nature of our study, it is not possible to conclude that the observed inverse association between nut consumption and mortality reflects cause and effect. However, our data are consistent with a wealth of existing observational and clinical-trial data in supporting the health benefits of nut consumption for many chronic diseases.14-23 In addition, nutrients in nuts, such as unsaturated fatty acids, high-quality protein, fiber, vitamins (e.g., folate, niacin, and vitamin E), minerals (e.g., potassium, calcium, and magnesium), and phytochemicals (e.g., carotenoids, flavonoids, and phytosterols), may confer cardioprotective, anticarcinogenic, antiinflammatory, and antioxidant properties.1,2 Indeed, clinical trials have shown that nut consumption has beneficial effects on some intermediate markers of chronic diseases, such as high cholesterol levels,3 oxidation,6,7 endothelial dysfunction,13 hyperglycemia,6,10 and insulin resistance.11,12 Moreover, recent findings from the PREDIMED trial have shown a protective effect of a Mediterranean diet against cardiovascular disease, and one component of the diet was the availability of an average of 30 g of nuts per day.5
In conclusion, our analysis of samples from these two prospective cohort studies showed significant inverse associations of nut consumption with total and cause-specific mortality. Nonetheless, epidemiologic observations establish associations, not causality, and not all findings from observational studies have been confirmed in controlled, randomized clinical trials.
Supported by grants from the National Institutes of Health (UM1 CA167552, P01 CA055075, P01 CA87969, R01 HL60712, R01 CA124908, P50 CA127003, and 1U54 CA155626-01) and the International Tree Nut Council Nutrition Research and Education Foundation.
Disclosure forms provided by the authors are available with the full text of this article at NEJM.org.
We thank the participants and staff of the Nurses' Health Study and the Health Professionals Follow-up Study for their valuable contributions.
Source Information
From the Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School (Y.B., F.B.H., E.L.G., M.J.S., W.C.W., C.S.F.), the Departments of Epidemiology (F.B.H., E.L.G., M.J.S., W.C.W.) and Nutrition (F.B.H., E.L.G., M.J.S., W.C.W.), Harvard School of Public Health, and the Department of Medical Oncology, Dana–Farber Cancer Institute (C.S.F.) — all in Boston; and the Department of Epidemiology, Richard M. Fairbanks School of Public Health, and Melvin and Bren Simon Cancer Center, Indiana University, Indianapolis (J.H.).
Address reprint requests to Dr. Bao at the Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, 181 Longwood Ave., Boston, MA 02115, or at ying.bao@channing.harvard.edu.
- References
References
1
Kris-Etherton PM Hu FB Ros E Sabate J
Web of Science | Medline2
Gonzalez CA Salas-Salvado J
CrossRef | Web of Science | Medline3
Sabate J Oda K Ros E
CrossRef | Web of Science | Medline4
Qualified health claims: letter of enforcement discretion — nuts and coronary heart disease. Rockville, MD: Food and Drug Administration, July 14, 2003.
5
Estruch R Ros E Salas-Salvado J
Free Full Text | Web of Science | Medline6
Jenkins DJ Kendall CW Josse AR
Web of Science | Medline7
Torabian S Haddad E Rajaram S Banta J Sabate J
CrossRef | Web of Science | Medline8
Jiang R Jacobs DR Jr Mayer-Davis E
CrossRef | Web of Science | Medline9
O'Neil CE Keast DR Nicklas TA Fulgoni VL III
CrossRef | Web of Science | Medline10
Jenkins DJ Kendall CW Banach MS
CrossRef | Web of Science | Medline11
Casas-Agustench P Lopez-Uriarte P Bullo M Ros E Cabre-Vila JJ Salas-Salvado J
CrossRef | Web of Science | Medline12
Tapsell LC Batterham MJ Teuss G
CrossRef | Web of Science | Medline13
Ma Y Njike VY Millet J
CrossRef | Web of Science | Medline14
Jiang R Manson JE Stampfer MJ Liu S Willett WC Hu FB
CrossRef | Web of Science | Medline15
Villegas R Gao YT Yang G
Web of Science | Medline16
Pan A Sun Q Manson JE Willett WC Hu FB
CrossRef | Web of Science | Medline17
Fernandez-Montero A Bes-Rastrollo M Beunza JJ
CrossRef | Web of Science | Medline18
Singh PN Fraser GE
CrossRef | Web of Science | Medline19
Djousse L Rudich T Gaziano JM
CrossRef | Web of Science | Medline20
Tsai CJ Leitzmann MF Hu FB Willett WC Giovannucci EL
CrossRef | Web of Science | Medline21
Tsai CJ Leitzmann MF Hu FB Willett WC Giovannucci EL
Web of Science | Medline22
Strate LL Liu YL Syngal S Aldoori WH Giovannucci EL
CrossRef | Web of Science | Medline23
Gopinath B Buyken AE Flood VM Empson M Rochtchina E Mitchell P
CrossRef | Web of Science | Medline24
Goldstein MR Fraser GE Sabate J Beeson WL
CrossRef | Web of Science25
Fraser GE Sumbureru D Pribis P Neil RL Frankson MA
CrossRef | Web of Science | Medline26
Fraser GE Shavlik DJ
CrossRef | Web of Science | Medline27
Mann JI Appleby PN Key TJ Thorogood M
CrossRef | Web of Science | Medline28
Ellsworth JL Kushi LH Folsom AR
Web of Science | Medline29
Baer HJ Glynn RJ Hu FB
CrossRef | Web of Science | Medline30
van den Brandt PA
CrossRef | Web of Science | Medline31
Guasch-Ferre M Bullo M Martinez-Gonzalez MA
CrossRef | Web of Science | Medline32
Salvini S Hunter DJ Sampson L
CrossRef | Web of Science | Medline33
Rich-Edwards JW Corsano KA Stampfer MJ
Web of Science | Medline34
Trichopoulou A Costacou T Bamia C Trichopoulos D
Free Full Text | Web of Science | Medline35
D'Agostino RB Jr
CrossRef | Web of Science | Medline36
Schneeweiss S
CrossRef | Web of Science | Medline37
Mozaffarian D Hao T Rimm EB Willett WC Hu FB
Free Full Text | Web of Science | Medline38
Salas-Salvado J Fernandez-Ballart J Ros E
CrossRef | Web of Science | Medline39
Bes-Rastrollo M Sabate J Gomez-Gracia E Alonso A Martinez JA Martinez-Gonzalez MA
CrossRef | Web of Science | Medline40
Bes-Rastrollo M Wedick NM Martinez-Gonzalez MA Li TY Sampson L Hu FB
CrossRef | Web of Science | Medline
- Citing Articles (70)
Citing Articles
1
Roberto Rosa, Lorenzo Tassi, Giulia Orteca, Monica Saladini, Carla Villa, Paolo Veronesi, Cristina Leonelli, Erika Ferrari. (2016) Process Intensification by Experimental Design Application to Microwave-Assisted Extraction of Phenolic Compounds from Juglans regia L.. Food Analytical Methods
CrossRef2
Chuan Shao, Hui Tang, Wei Zhao, Jianquan He. (2016) Nut intake and stroke risk: A dose-response meta-analysis of prospective cohort studies. Scientific Reports 6, 30394
CrossRef3
Weike Wang, Meng Yang, Stacey A Kenfield, Frank B Hu, Meir J Stampfer, Walter C Willett, Charles S Fuchs, Edward L Giovannucci, Ying Bao. (2016) Nut consumption and prostate cancer risk and mortality. British Journal of Cancer 115:3, 371-374
CrossRef4
Melina B. Jampolis, Michael M. Rothkopf, Zhaoping Li, Sarah J. Diamond, Karen Allen, Ruba A. Abdelhadi, Doron D. Kahana, Stephen A. McClave. (2016) Principles of Healthful Eating. Current Nutrition Reports
CrossRef5
Jeffrey A. Sparks, Shun-Chiao Chang, Katherine P. Liao, Bing Lu, Alexander R. Fine, Daniel H. Solomon, Karen H. Costenbader, Elizabeth W. Karlson. (2016) Rheumatoid Arthritis and Mortality Among Women During 36 Years of Prospective Follow-Up: Results From the Nurses’ Health Study. Arthritis Care & Research 68:6, 753-762
CrossRef6
Rosa M Lamuela-Raventos, Marie-Pierre St Onge. (2016) Prebiotic Nut Compounds and Human Microbiota. Critical Reviews in Food Science and Nutrition, 00-00
CrossRef7
Cem Ekmekcioglu, Peter Wallner, Michael Kundi, Ulli Weisz, Willi Haas, Hans-Peter Hutter. (2016) Red meat, diseases and healthy alternatives: A critical review. Critical Reviews in Food Science and Nutrition, 00-00
CrossRef8
Katharina Lechner, Klaus G. Parhofer. (2016) So steuern Sie das Essverhalten Ihrer Patienten in die richtige Richtung. MMW - Fortschritte der Medizin 158:7, 41-46
CrossRef9
Zohreh Abazarfard, Ghazaleh Eslamian, Mousa Salehi, Sareh Keshavarzi. (2016) A Randomized Controlled Trial of the Effects of an Almond-enriched, Hypocaloric Diet on Liver Function Tests in Overweight/Obese Women. Iranian Red Crescent Medical Journal 18:3
CrossRef10
Tannaz Eslamparast, Maryam Sharafkhah, Hossein Poustchi, Maryam Hashemian, Sanford M Dawsey, Neal D. Freedman, Paolo Boffetta, Christian C. Abnet, Arash Etemadi, Akram Pourshams, Akbar Fazeltabar Malekshah, Farhad Islami, Farin Kamangar, Shahin Merat, Paul Brennan, Azita Hekmatdoost, Reza Malekzadeh. (2016) Nut consumption and total and cause-specific mortality: results from the Golestan Cohort Study. International Journal of Epidemiology, dyv365
CrossRef11
Evan L. O’Keefe, James J. DiNicolantonio, Harshal Patil, John H. Helzberg, Carl J. Lavie. (2016) Lifestyle Choices Fuel Epidemics of Diabetes and Cardiovascular Disease Among Asian Indians. Progress in Cardiovascular Diseases 58:5, 505-513
CrossRef12
Katherine R. Pearson, Siew Ling Tey, Andrew R. Gray, Alexandra Chisholm, Rachel C. Brown. (2016) Energy compensation and nutrient displacement following regular consumption of hazelnuts and other energy-dense snack foods in non-obese individuals. European Journal of Nutrition
CrossRef13
Alexandra J. Mayhew, Russell J. de Souza, David Meyre, Sonia S. Anand, Andrew Mente. (2016) A systematic review and meta-analysis of nut consumption and incident risk of CVD and all-cause mortality. British Journal of Nutrition 115:02, 212-225
CrossRef14
Rachel C. Brown, Siew Ling Tey, Andrew R. Gray, Alex Chisholm, Claire Smith, Elizabeth Fleming, Winsome Parnell. (2016) Nut consumption is associated with better nutrient intakes: results from the 2008/09 New Zealand Adult Nutrition Survey. British Journal of Nutrition 115:01, 105-112
CrossRef15
E. Ros. . Nuts: Health Effects. 2016:, 111-118.
CrossRef16
Carol E. O’Neil, Theresa A. Nicklas, Victor L. Fulgoni III. (2016) Almond Consumption Is Associated with Better Nutrient Intake, Nutrient Adequacy, and Diet Quality in Adults: National Health and Nutrition Examination Survey 2001-2010. Food and Nutrition Sciences 07:07, 504-515
CrossRef17
Jack P. Davis, Lisa L. Dean. . Peanut Composition, Flavor and Nutrition. 2016:, 289-345.
CrossRef18
Adopting a Diet. 2015:, 331-380.
CrossRef19
Roberta R. Holt, Sun J. Yim, Gregory C. Shearer, Robert M. Hackman, Dragana Djurica, John W. Newman, Alan W. Shindel, Carl L. Keen. (2015) Effects of short-term walnut consumption on human microvascular function and its relationship to plasma epoxide content. The Journal of Nutritional Biochemistry 26:12, 1458-1466
CrossRef20
C. Dawczynski, M.E. Kleber, W. März, G. Jahreis, S. Lorkowski. (2015) Saturated fatty acids are not off the hook. Nutrition, Metabolism and Cardiovascular Diseases 25:12, 1071-1078
CrossRef21
B. Gopinath, V.M. Flood, G. Burlutksy, P. Mitchell. (2015) Consumption of nuts and risk of total and cause-specific mortality over 15 years. Nutrition, Metabolism and Cardiovascular Diseases 25:12, 1125-1131
CrossRef22
Ilaria Casari, Marco Falasca. (2015) Diet and Pancreatic Cancer Prevention. Cancers 7:4, 2309-2317
CrossRef23
Carol E. O’Neil, Victor L. Fulgoni, Theresa A. Nicklas. (2015) Tree Nut consumption is associated with better adiposity measures and cardiovascular and metabolic syndrome health risk factors in U.S. Adults: NHANES 2005–2010. Nutrition Journal 14:1
CrossRef24
Demetrius Ellis, Jessica Lieb. (2015) Hyperoxaluria and Genitourinary Disorders in Children Ingesting Almond Milk Products. The Journal of Pediatrics 167:5, 1155-1158
CrossRef25
Katherine S. Robbins, Yi Gong, M. Lenny Wells, Phillip Greenspan, Ronald B. Pegg. (2015) Reprint of “Investigation of the antioxidant capacity and phenolic constituents of U.S. pecans”. Journal of Functional Foods 18, 1002-1013
CrossRef26
Alejandro Fernández-Montero, Miguel Angel Martínez-González, Laura Moreno-Galarraga. (2015) Re. “Nut consumption and 5-y all-cause mortality in a Mediterranean cohort: The SUN project”: Authors' response. Nutrition 31:10, 1299-1300
CrossRef27
I. Hollan, P.H. Dessein, N. Ronda, M.C. Wasko, E. Svenungsson, S. Agewall, J.W. Cohen-Tervaert, K. Maki-Petaja, M. Grundtvig, G.A. Karpouzas, P.L. Meroni. (2015) Prevention of cardiovascular disease in rheumatoid arthritis. Autoimmunity Reviews 14:10, 952-969
CrossRef28
Nicole Martin, Roberta Germanò, Louise Hartley, Alma J Adler, Karen Rees, Karen Rees. . Nut consumption for the primary prevention of cardiovascular disease. 2015.
CrossRef29
Marialaura Bonaccio, Augusto Di Castelnuovo, Amalia De Curtis, Simona Costanzo, Francesca Bracone, Mariarosaria Persichillo, Maria Benedetta Donati, Giovanni de Gaetano, Licia Iacoviello. (2015) Nut consumption is inversely associated with both cancer and total mortality in a Mediterranean population: prospective results from the Moli-sani study. British Journal of Nutrition 114:05, 804-811
CrossRef30
Rachel Brown, Siew Tey, Andrew Gray, Alexandra Chisholm, Claire Smith, Elizabeth Fleming, Winsome Parnell. (2015) Association of Nut Consumption with Cardiometabolic Risk Factors in the 2008/2009 New Zealand Adult Nutrition Survey. Nutrients 7:9, 7523-7542
CrossRef31
Sara Bonafini, Franco Antoniazzi, Claudio Maffeis, Pietro Minuz, Cristiano Fava. (2015) Beneficial effects of ω-3 PUFA in children on cardiovascular risk factors during childhood and adolescence. Prostaglandins & Other Lipid Mediators 120, 72-79
CrossRef32
L. Wu, Z. Wang, J. Zhu, A. L. Murad, L. J. Prokop, M. H. Murad. (2015) Nut consumption and risk of cancer and type 2 diabetes: a systematic review and meta-analysis. Nutrition Reviews 73:7, 409-425
CrossRef33
Piet A van den Brandt, Leo J Schouten. (2015) Relationship of tree nut, peanut and peanut butter intake with total and cause-specific mortality: a cohort study and meta-analysis. International Journal of Epidemiology 44:3, 1038-1049
CrossRef34
Geeta Sikand, Penny Kris-Etherton, Nancy Mariam Boulos. (2015) Impact of Functional Foods on Prevention of Cardiovascular Disease and Diabetes. Current Cardiology Reports 17:6
CrossRef35
Katherine S. Robbins, Yi Gong, M. Lenny Wells, Phillip Greenspan, Ronald B. Pegg. (2015) Investigation of the antioxidant capacity and phenolic constituents of U.S. pecans. Journal of Functional Foods 15, 11-22
CrossRef36
Deanna Minich, Benjamin Brown. . Healing the Heart with Whole Foods and Food Bioactives. 2015:, 103-146.
CrossRef37
Emilio Ros. (2015) Nuts and CVD. British Journal of Nutrition 113:S2, S111-S120
CrossRef38
Siew Ling Tey, Conor Delahunty, Andrew Gray, Alexandra Chisholm, Rachel Clare Brown. (2015) Effects of regular consumption of different forms of almonds and hazelnuts on acceptance and blood lipids. European Journal of Nutrition 54:3, 483-487
CrossRef39
Cesarettin Alasalvar, Bradley W. Bolling. (2015) Review of nut phytochemicals, fat-soluble bioactives, antioxidant components and health effects. British Journal of Nutrition 113:S2, S68-S78
CrossRef40
M. Bulló, M. Juanola-Falgarona, P. Hernández-Alonso, J. Salas-Salvadó. (2015) Nutrition attributes and health effects of pistachio nuts. British Journal of Nutrition 113:S2, S79-S93
CrossRef41
R di Giuseppe, M K Fjeld, J Dierkes, D Theoflylaktopoulou, M Arregui, H Boeing, C Weikert. (2015) The association between nut consumption and the risk of total and ischemic stroke in a German cohort study. European Journal of Clinical Nutrition 69:4, 431-435
CrossRef42
Zhizhong Zhang, Gelin Xu, Yongyue Wei, Wusheng Zhu, Xinfeng Liu. (2015) Nut consumption and risk of stroke. European Journal of Epidemiology 30:3, 189-196
CrossRef43
Sean P. Heffron, Caron B. Rockman, Eugenia Gianos, Yu Guo, Jeffrey S. Berger. (2015) Greater frequency of nut consumption is associated with lower prevalence of peripheral arterial disease. Preventive Medicine 72, 15-18
CrossRef44
Sean C Lucan, James J DiNicolantonio. (2015) How calorie-focused thinking about obesity and related diseases may mislead and harm public health. An alternative. Public Health Nutrition 18:04, 571-581
CrossRef45
Mengfei Peng, Elizabeth Bitsko, Debabrata Biswas. (2015) Functional Properties of Peanut Fractions on the Growth of Probiotics and Foodborne Bacterial Pathogens. Journal of Food Science 80:3, M635-M641
CrossRef46
Alberta N. A. Aryee, Joyce Irene Boye. . Role and Importance of Health Claims in the Nutraceutical and Functional Food Markets. 2015:, 347-374.
CrossRef47
Alberta N. A. Aryee, Joyce Irene Boye. . Current and Emerging Trends in the Formulation and Manufacture of Nutraceuticals and Functional Food Products. 2015:, 1-63.
CrossRef48
Burkhard Alber, Robert Müller, Gerhard F. Hamann. (2015) Risikofaktoren für Schlaganfall und ihre therapeutische Beeinflussung. DNP - Der Neurologe und Psychiater 16:2, 32-44
CrossRef49
Giuseppe Potrick Stefani, Giovana Baldissera, Ramiro Barcos Nunes, Thiago Gomes Heck, Cláudia Ramos Rhoden. (2015) Metabolic Syndrome and DNA Damage: The Interplay of Environmental and Lifestyle Factors in the Development of Metabolic Dysfunction. Open Journal of Endocrine and Metabolic Diseases 05:07, 65-76
CrossRef50
Daniele Massera, Tarique Zaman, Grace E. Farren, Robert J. Ostfeld. (2015) A Whole-Food Plant-Based Diet Reversed Angina without Medications or Procedures. Case Reports in Cardiology 2015, 1-3
CrossRef51
Liya Wu, Klaus G. Parhofer. (2014) Diabetic dyslipidemia. Metabolism 63:12, 1469-1479
CrossRef52
Hyunsook Kim, Wallace Yokoyama, Paul Andrew Davis. (2014) TRAMP Prostate Tumor Growth Is Slowed by Walnut Diets Through Altered IGF-1 Levels, Energy Pathways, and Cholesterol Metabolism. Journal of Medicinal Food 17:12, 1281-1286
CrossRef53
Pablo Hernández-Alonso, Jordi Salas-Salvadó, Mònica Baldrich-Mora, Martí Juanola-Falgarona, Mònica Bulló. (2014) Beneficial Effect of Pistachio Consumption on Glucose Metabolism, Insulin Resistance, Inflammation, and Related Metabolic Risk Markers: A Randomized Clinical Trial. Diabetes Care 37:11, 3098-3105
CrossRef54
Miguel Martinez-Gonzalez, Maira Bes-Rastrollo. . Nutrition and Cardiovascular Disease. 2014:, 141-164.
CrossRef55
Ling Ma, Fei Wang, Wenyun Guo, Hongning Yang, Yan Liu, Weize Zhang. (2014) Nut consumption and the risk of coronary artery disease: A dose–response meta-analysis of 13 prospective studies. Thrombosis Research 134:4, 790-794
CrossRef56
M. Falasca, I. Casari, T. Maffucci. (2014) Cancer Chemoprevention With Nuts. JNCI Journal of the National Cancer Institute 106:9, dju238-dju238
CrossRef57
Simone D. Holligan, Sheila G. West, Sarah K. Gebauer, Colin D. Kay, Penny M. Kris-Etherton. (2014) A moderate-fat diet containing pistachios improves emerging markers of cardiometabolic syndrome in healthy adults with elevated LDL levels. British Journal of Nutrition 112:05, 744-752
CrossRef58
Karen L. Sweazea, Carol S. Johnston, Kristin D. Ricklefs, Katherine N. Petersen. (2014) Almond supplementation in the absence of dietary advice significantly reduces C-reactive protein in subjects with type 2 diabetes. Journal of Functional Foods 10, 252-259
CrossRef59
A. Fernández-Montero, M. Bes-Rastrollo, M.T. Barrio-López, C. de la Fuente-Arrillaga, J. Salas-Salvadó, L. Moreno-Galarraga, M.A. Martínez-González. (2014) Nut consumption and 5-y all-cause mortality in a Mediterranean cohort: The SUN project. Nutrition 30:9, 1022-1027
CrossRef60
Serajus Salaheen, Brittany White, Brian J. Bequette, Debabrata Biswas. (2014) Peanut fractions boost the growth of Lactobacillus casei that alters the interactions between Campylobacter jejuni and host epithelial cells. Food Research International 62, 1141-1146
CrossRef61
Mar Garcia-Aloy, Rafael Llorach, Mireia Urpi-Sarda, Sara Tulipani, Ramon Estruch, Miguel A. Martínez-González, Dolores Corella, Montserrat Fitó, Emilio Ros, Jordi Salas-Salvadó, Cristina Andres-Lacueva. (2014) Novel Multimetabolite Prediction of Walnut Consumption by a Urinary Biomarker Model in a Free-Living Population: the PREDIMED Study. Journal of Proteome Research 13:7, 3476-3483
CrossRef62
Jane Stock. (2014) Focus on lifestyle: EAS Consensus Panel Position Statement on Phytosterol-added Foods. Atherosclerosis 234:1, 142-145
CrossRef63
Nathan A. Berger. (2014) Obesity and cancer pathogenesis. Annals of the New York Academy of Sciences 1311:1, 57-76
CrossRef64
(2014) Nut Consumption and Mortality. New England Journal of Medicine 370:9, 881-882
Free Full Text65
Stephen T. Sinatra, Beverly B. Teter, Jonny Bowden, Mark C. Houston, Miguel A. Martinez-Gonzalez. (2014) The Saturated Fat, Cholesterol, and Statin Controversy A Commentary. Journal of the American College of Nutrition 33:1, 79-88
CrossRef66
- Krebsinformationsdienst, A. Gaisser. (2014) Onkologie und Versorgung in Fach- und Publikumsmedien. Der Onkologe 20:2, 169-172
CrossRef67
Tor Atle Rosness. (2014) Spis nøtter – lev lenger?. Tidsskrift for Den norske legeforening 134:4, 400-400
CrossRef68
Cheryl D. Toner. (2014) Communicating clinical research to reduce cancer risk through diet: Walnuts as a case example. Nutrition Research and Practice 8:4, 347
CrossRef69
Carol Wilson. (2013) Nutrition: Consuming nuts frequently might help extend life. Nature Reviews Endocrinology 10:2, 64-64
CrossRef70
Douglas Weidner, John Girard. . Moneyball for Knowledge Management. :, 51-64.
CrossRef
- Letters
- Metrics
Social Media statistics are not yet available.